Literature DB >> 6120140

Lanthanum chloride inhibition of the secretory response to Escherichia coli heat-stable enterotoxin.

R N Greenberg, F Murad, R L Guerrant.   

Abstract

Escherichia coli heat-stable enterotoxin (ST) appears to cause intestinal fluid secretion by activating intestinal particulate guanylate cyclase. Recent studies suggest that chlorpromazine and quinacrine reduce the intestinal secretory response to ST and activation of guanylate cyclase by ST. We have examined the effects of lanthanum chloride, another agent that has been shown to inhibit calcium-dependent cellular processes, on the intestinal secretory response to ST and on the inhibition of ST by chlorpromazine and quinacrine. Lanthanum (2.5 to 10 mumol per mouse) reduced ST-mediated intestinal fluid secretion in the suckling mouse assay by 40 to 56%, respectively, but did not reduce basal fluid accumulation or ST activation of particulate guanylate cyclase. Intestinal fluid secretion in suckling mice induced by 8-bromocyclic GMP was also reduced by lanthanum. When subeffective doses of lanthanum and chlorpromazine were combined, they blocked both ST- and 8-bromocyclic GMP-mediated gut secretion in suckling mice. Likewise, the combination of subeffective doses of lanthanum and quinacrine reduced ST-mediated gut secretion in suckling mice. However, 8-bromocyclic GMP-induced secretion was not synergistically inhibited by lanthanum and quinacrine. These results suggest that lanthanum blocks ST-induced secretion after ST activation of guanylate cyclase. Additionally, lanthanum potentiates the inhibitory effects of quinacrine and chlorpromazine on ST and suggests that combination antisecretory therapy deserves further exploration.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6120140      PMCID: PMC351066          DOI: 10.1128/iai.35.2.483-488.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  Lanthanum inhibition of Vibrio cholerae and Escherichia coli enterotoxin-induced enterosorption and its effects on intestinal mucosa cyclic adenosine 3',5'-monophosphate and cyclic guanosine 3',5'-monophosphate levels.

Authors:  G J Leitch; M S Amer
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

2.  Stimulation of adenyl cyclase by Escherichia coli enterotoxin.

Authors:  D J Evans; L C Chen; G T Curlin; D G Evans
Journal:  Nat New Biol       Date:  1972-04-05

3.  Radioimmunoassay for cyclic nucleotides. I. Preparation of antibodies and iodinated cyclic nucleotides.

Authors:  A L Steiner; C W Parker; D M Kipnis
Journal:  J Biol Chem       Date:  1972-02-25       Impact factor: 5.157

4.  Selective inhibition by mepacrine of the release of "rabbit aorta contracting substance" evoked by the administration of bradykinin.

Authors:  B B Vargaftig; N D Hai
Journal:  J Pharm Pharmacol       Date:  1972-02       Impact factor: 3.765

5.  Intestinal adenyl-cyclase activity in human cholera.

Authors:  L C Chen; J E Rohde; G W Sharp
Journal:  Lancet       Date:  1971-05-08       Impact factor: 79.321

6.  Intestinal adenyl-cyclase activity in canine cholera: correlation with fluid accumulation.

Authors:  R L Guerrant; L C Chen; G W Sharp
Journal:  J Infect Dis       Date:  1972-04       Impact factor: 5.226

7.  The importance of phospholipase-A2 in prostaglandin biosynthesis.

Authors:  R J Flower; G J Blackwell
Journal:  Biochem Pharmacol       Date:  1976-02-01       Impact factor: 5.858

8.  Femtomole sensitive radioimmunoassay for cyclic AMP and cyclic GMP after 2'0 acetylation by acetic anhydride in aqueous solution.

Authors:  J F Harper; G Brooker
Journal:  J Cyclic Nucleotide Res       Date:  1975

9.  Test for Escherichia coli enterotoxin using infant mice: application in a study of diarrhea in children in Honolulu.

Authors:  A G Dean; Y C Ching; R G Williams; L B Harden
Journal:  J Infect Dis       Date:  1972-04       Impact factor: 5.226

10.  Effect of Escherichia coli on fluid transport across canine small bowel. Mechanism and time-course with enterotoxin and whole bacterial cells.

Authors:  R L Guerrant; U Ganguly; A G Casper; E J Moore; N F Pierce; C C Carpenter
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

View more
  8 in total

Review 1.  Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion.

Authors:  C L Sears; J B Kaper
Journal:  Microbiol Rev       Date:  1996-03

2.  Calcium inhibits paracellular sodium conductance through claudin-2 by competitive binding.

Authors:  Alan S L Yu; Mary H Cheng; Rob D Coalson
Journal:  J Biol Chem       Date:  2010-08-31       Impact factor: 5.157

3.  Reversal of the biological activity of Escherichia coli heat-stable enterotoxin by disulfide-reducing agents.

Authors:  M M ElDeib; C R Dove; C D Parker; T L Veum; G M Zinn; A A White
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

4.  Characterization of the mechanism of action of Escherichia coli heat-stable enterotoxin.

Authors:  L A Dreyfus; L Jaso-Friedmann; D C Robertson
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

5.  Reduction of the secretory response to Escherichia coli heat-stable enterotoxin by thiol and disulfide compounds.

Authors:  R N Greenberg; J A Dunn; R L Guerrant
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

6.  Berberine inhibition of electrogenic ion transport in rat colon.

Authors:  C T Taylor; A W Baird
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

7.  Diarrhea or colorectal cancer: can bacterial toxins serve as a treatment for colon cancer?

Authors:  S L Carrithers
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-11       Impact factor: 11.205

8.  Stimulation of calcium uptake and cyclic GMP synthesis in rat basophilic leukemia cells by Escherichia coli heat-stable enterotoxin.

Authors:  F C Knoop; D D Thomas
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.